Baijiu plate strength, mouth cellar line exceeds 10%

Synthetic Biology: Who Will Emerge as the Winner?

The 21st century is the century of biology. Synthetic biology is believed to be a ‘World Changing’ industry. But the potential risks like cost control and commercialization pathways are fatefully tied to the ups and downs of countless investment decisions and the destiny of the many new start-ups getting involved. We look forward to seeing an emerging ‘giant’ on the horizon of this exciting industry.

ZEEKR MAKES PARIS MOTOR SHOW DEBUT ON THE BACK OF 200% YEAR ON YEAR GROWTH IN EUROPE

The brand sets out its long-term commitment to Europe and expansion plans, and unveils the Zeekr 9X, its first luxury model, reflecting its New Class of Luxury vision, alongside the all-new Zeekr 7X, to European automotive audiences.

Runjian Signs US$200 Million Overseas AI Inference Contract, Keeping Computing Resources in China

Runjian（润建股份）disclosed on October 18 that its wholly owned subsidiary Wuxiang Yungu（五象云谷）had signed a one-year AI token services contract with an unidentified overseas company. The agreement includes a US$200 million minimum annual purchase commitment, equivalent to approximately CNY 1.338 billion, with computing resources hosted in China and services accessed remotely through an API.

EqualOcean｜China's Top 20 ESG Performers Among Private Enterprises（Part III）

Private enterprises are actively embracing the transformative era

Bloomage: Injecting Biotechnology into Beauty Care

Listed on the Chinese Star Market in November 2019, Bloomage was trading at CNY 138.01 as of June 24, 2020, over 38% higher than the IPO price of CNY 100.